Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 19/20 | 0.69 |
| ▸ | NPY1R | P25929 | 1/20 | 0.61 |
| ▸ | NPY2R | P49146 | 1/20 | 0.61 |
| ▸ | NPY4R | P50391 | 1/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.60 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.60 |
| ▸ | CCKBR | P32239 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30906543 | 0.97 | GLP1R (0.64) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30906394 | 0.97 | GLP1R (0.64) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30906370 | 0.95 | GLP1R (0.62) | GLP1RCCKBR | |
| SCHEMBL30906359 | 0.95 | GLP1R (0.63) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29479845 | 0.94 | GLP1R (0.69) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30726576 | 0.93 | GLP1R (0.69) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29679739 | 0.92 | GLP1R (0.65) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31547376 | 0.91 | GLP1R (0.70) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30648497 | 0.91 | GLP1R (0.64) | GLP1RCCKBR | |
| SCHEMBL31000884 | 0.91 | NPY2R (0.75) | GLP1RNPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630447-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | Abwiz Bio, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024124241-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | ABWIZ BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |